Anti-C1q antibodies and their association with complement components in Indian systemic lupus erythematosus patients

Indian Journal of Nephrology

Volumn 22, Issue 5, 2012, Pages 353-357

  Pradhan, V ^a   Rajadhyaksha, A ^a   Mahant, G ^a   Surve, P ^a   Patwardhan, M ^a   Dighe, S ^a   Ghosh, K ^a  

^a KEM HOSPITAL   (India)

Author keywords

Anti C1q antibodies; C3; C4; lupus nephritis; mannose binding lectin; SLE without nephritis (non LN); systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; MANNOSE BINDING LECTIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84871754768     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.103911     Document Type: Article

References (30)

1. Monticielo OA, Mucenic T, Xavier RM, Brenol JC, Chies JA. The role of mannose-binding lectin in systemic lupus erythematosus. Clin Rheumatol 2008;27:413-9. (Pubitemid 351404295)
2. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004;34:501-37. (Pubitemid 40288129)
3. HorákP, Zadrazil J, Ciferská H, Hermanová Z. Antibodies against complement system in SLE and their diagnostic utility. Curr Rheumatol Rev 2009;5:58-63.
4. Mitchell DA, Taylor PR, Cook HT, Moss J, Bygrave AE, Walport MJ, et al. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J Immunol 1999;162:5676-9. (Pubitemid 29314916)
5. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-9. (Pubitemid 28242023)
6. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Ststemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000;76:227-324.
7. Kelley JM, Edberg JC, Kimberley RP. Pathways: Strategies for susceptibility genes in SLE. Autoimmun Rev 2010;9:473-6.
8. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementamia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991;18:230-4.
9. Monova D, Monov S, Argirova T, Rosenova K, Todorov T, RadenskaLopovok S. Significance of anti-C1q antibodies in lupus nephritis. BANTAO J 2009;7:14-7.
10. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Anti-C1q antibodies in nephritis: Correlation between titers and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 2005;64:444-8. (Pubitemid 40283057)
11. Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995;26:595-601.
12. Coremans IE, Daha MR, van der Voort EA, Siegert CE, Breedveld FC. Subclass distribution of IgA and IgG antibodies against Clq in patients with rheumatic diseases. Scand J Immunol 1995;41:391-7.
13. Hockberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-5.
14. Bombardier C, Gladmsn FF, Urowit MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
15. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50. (Pubitemid 38140764)
16. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, et al. High prevalence of anti-C1q antibodies in biopsy proven active lupus nephritis. Nephrol Dial Transplant 2006;21:3115-21. (Pubitemid 44567082)
17. Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, et al. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res Ther 2009;11:R87.
18. Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, et al. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann N Y Acad Sci 2005;1050:193-200. (Pubitemid 41129436)
19. Tan Y, Zhou W, Yu F, Fang Q, Yang HZ, Zhao MH. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Mol Immunol 2009;46:2178-82.
20. Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, et al. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant 2009;24:172-8.
21. Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Clin Rheumatol 2011;30:967-73.
22. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, et al. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity, but not specifically with nephritis: A controlled study of 126 consecutive patients. Arthritis Rheum 2011;63:2436-44.
23. Schaller M, Bigler C, Danner D, Ditzel HJ, Trendelenburg M. Autoantibodies against C1q in Systemic Lupus Erythematosus are antigen-driven. J Immunol 2009;183:8225-31.
24. Chen PC, Wang CR, Liu MF, Chen FF, Liang CC. Correlation between the renal C1q deposition and serum anti-C1q antibody in lupus nephritis. Asian Pac J Allergy Immunol 2002;20:223-7.
25. Moura CG, Lima I, Barbosa L, Athanazio D, Reis E, Reis M, et al. Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus. J Clin Lab Anal 2009;23:19-23.
26. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A, et al. Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: Prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 2007;1108:227-39. (Pubitemid 47528736)
27. Pradhan V, Patwardhan M, Nadkarni A, Ghosh K. Fc γ RIIA Genotypes and Its Association with Anti-C1q Autoantibodies in Lupus Nephritis (LN) Patients from Western India. Autoimmune Dis 2010;2010:470695.
28. Enghard P, Riemekasten G. Immunology and the diagnosis of lupus nephritis. Lupus 2009;18:287-90.
29. Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009;68:234-7.
30. Martensson U, Theil S, Jensenius JC, Sjoholm AG. Human autoantibodies against C1q: lack of cross reactivity with collectins mannan-binding protein, lung surfactant protein A and bovine conglutinin. Scand J Immunol 1996;43:314-20.